<DOC>
	<DOCNO>NCT01577459</DOCNO>
	<brief_summary>This randomize , double-blinded , placebo-controlled , crossover study evaluate pressor effect pseudoephedrine administer TR-701 FA healthy adult volunteer .</brief_summary>
	<brief_title>A Phase 1 Crossover Study Blood Pressure Heart Rate Response</brief_title>
	<detailed_description>Eligible subject randomize 1 2 possible treatment sequence ( N=9 per sequence ) Study Day 1 . Subjects receive oral 200 mg TR 701 FA Placebo TR 701 FA daily 5 day treatment period , 2 day washout period ( 72 hour dos ) . On Study Day 5 treatment period , subject also receive oral 60 mg PSE .</detailed_description>
	<mesh_term>Torezolid phosphate</mesh_term>
	<criteria>Male female subject 18 45 year age , inclusive Healthy male females clinically significant abnormality identify detailed medical history Body mass index ≥ 19.0 kg/m2 ≤ 31.0 kg/m2 Systolic blood pressure &gt; 130 mmHg &lt; 90 mmHg measure 10 minute supine Screening Visit Study Day 1 Diastolic blood pressure &gt; 90 mmHg &lt; 60 mmHg measure 10 minute supine Screening Visit Study Day 1 Heart rate &gt; 90 bpm &lt; 50 bpm measure 10 minute supine Screening Visit Study Day Known allergy hypersensitivity PSE</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>